Lilly, JDRF enter research agreement
INDIANAPOLIS — Drug maker Eli Lilly and the Juvenile Diabetes Research Foundation will fund research to find ways to regenerate insulin-producing cells in patients with Type 1 diabetes.
The two announced Thursday that ideas included finding ways to grow new insulin-producing cells within a person’s body. Type 1 diabetes, also known as juvenile diabetes, is an autoimmune disease in which the immune system attacks beta cells, the cells that allow the body to produce insulin. As many as 3 million people in the United States have Type 1 diabetes.
“The goal of this research agreement [between Eli Lilly and JDRF] is to understand how selected cells can be reprogrammed in order to convert them into insulin-producing cells in the body,” Lilly chief scientific officer for diabetes drug discovery Philip Larsen said. “This research is an example of regenerative medicine, a new frontier in science that replaces or regenerates new cells, tissues or organs, and while this particular research is early-stage, it may ultimately lead to new approaches to treating Type 1 diabetes.”
NCPA responds to repeal of 1099 reporting provision
ALEXANDRIA, Va. — The National Community Pharmacists Association expressed its support of the Senate’s decision to repeal the 1099 tax reporting mandate for businesses.
The Senate announced it passed an amendment that repealed a requirement for businesses to file 1099 forms with the Internal Revenue Service beginning in 2012 any time they spend more than $600 a year with any other business. NCPA EVP and CEO Kathleen Jaeger said that the business tax provision would have shifted community pharmacies focus from "clinical to clerical."
“We applaud the Senate for this bipartisan vote to repeal the 1099 provision, because full compliance with this requirement would prove daunting for independently owned pharmacy small businesses with limited staff and financial resources," Jaeger said. "Most importantly, our patients would suffer because the pharmacists would have less time to spend with them [to provide] invaluable prescription drug services and counseling."
Chauncey Billups tapped as Vaccines for Teens spokesman
NEW YORK — Chauncey Billups, point guard for the NBA’s Denver Nuggets team, was named the latest spokesman for a national multimedia campaign designed to educate preteens, teens and their parents about the importance of vaccination against serious, potentially life-threatening diseases.
As the latest spokesman for Vaccine for Teens, Billups will be featured in a new public service announcement, which will air on NBA media and network/cable game broadcasts.
Vaccine for Teens, which launched last year, is a collaboration between NBA Cares, the Society for Adolescent Health and Medicine, and Sanofi Pasteur, the vaccines business of Sanofi-Aventis.